2020年美国食品药品监督管理局批准的靶向蛋白激酶的抗癌药物
Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020.
作者信息
Cicenas Jonas, Račienė Asta
机构信息
Proteomics Center, Institute of Biochemistry, Vilnius University Life Sciences Center, Sauletekio al. 7, LT-10257 Vilnius, Lithuania.
MAP Kinase Resource, Bioinformatics, Melchiorstrasse 9, CH-3027 Bern, Switzerland.
出版信息
Cancers (Basel). 2021 Feb 24;13(5):947. doi: 10.3390/cancers13050947.
Abstract
Cancers are a large group of diseases that mostly emerge because of the uncontrollable action of many different genes in human cells [...].
摘要
癌症是一大类疾病，大多是由于人类细胞中许多不同基因的失控作用而产生的[……]。
Zotero 插件